"En Neuropsique nuestro compromiso es brindar a nuestros pacientes una atención de la más alta calidad con lo último en el tratamiento para las diversas patologías psiquiátricas y conductuales. Contamos con los avances más recientes en Psiquiatría y Neurociencias para el tratamiento de la Esquizofrenia y diversas psicosis."

During the past decade, cit NEUROPSIQUE conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "cit NEUROPSIQUE" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Gedeon Richter Plc." with 1 trials sponsored, "Janssen-Cilag, S.A." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "cit NEUROPSIQUE" are "Depressive Disorder, Major" (3 trials), "Schizophrenia" (3 trials), "Anhedonia" (1 trials), "Borderline Personality Disorder" (1 trials) and "Depressive Disorder, Treatment-Resistant" (1 trials). Many other conditions were trialed in "cit NEUROPSIQUE" in a lesser frequency.

Most popular intervention types in "cit NEUROPSIQUE" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Aticaprant" (2 trials), "BI 1358894" (2 trials), "BI 425809" (1 trials) and "Cariprazine" (1 trials). Other intervention names were less common.

The vast majority of trials in "cit NEUROPSIQUE" are 11 trials for "All" genders.

Currently, there are NaN active trials in "cit NEUROPSIQUE". undefined are not yet recruiting, 8 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in cit NEUROPSIQUE, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in cit NEUROPSIQUE, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".